Cells use 'battering ram' to get around cancer drug

Drug can boost long-term memory of objects

Reduced U.S. life expectancy is not just for the Baby Boomers

New treatment option for patients who no longer respond to hormone therapy

Lorcaserin decreased risk for diabetes, induced diabetes remission, and reduced risk of diabetes complications in obese and overweight patients

3,000 backlogged cases, number is growing

Large NIH-funded study examined outcomes in the United States and Australia

The discovery could help scientists develop new pathways for plants to battle infection

For the first time, a team of international researchers has mapped the family trees of cancer cells in acute myeloid leukaemia to understand how this blood cancer responds to a new drug, enasidenib

In pharmacology, not all molecular structures are created equal